Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes
ImportanceRisk factors for atherosclerotic cardiovascular disease (ASCVD) are well established in type 2 diabetes (T2D), but not in type 1 diabetes (T1D). The impact of partial clinical remission (PR) on short-term ASCVD risk in T1D is unclear.AimTo investigate the impact of PR on the earliest ASCVD...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/31ba85162293457e91654a534717c767 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:31ba85162293457e91654a534717c767 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:31ba85162293457e91654a534717c7672021-11-17T06:10:17ZPartial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes1664-239210.3389/fendo.2021.705565https://doaj.org/article/31ba85162293457e91654a534717c7672021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fendo.2021.705565/fullhttps://doaj.org/toc/1664-2392ImportanceRisk factors for atherosclerotic cardiovascular disease (ASCVD) are well established in type 2 diabetes (T2D), but not in type 1 diabetes (T1D). The impact of partial clinical remission (PR) on short-term ASCVD risk in T1D is unclear.AimTo investigate the impact of PR on the earliest ASCVD risk phenotype in adult T1D using factor analysis to compare the lipid phenotypes of T1D, T2D and controls after stratifying the T1D cohort into remitters and non-remitters.Subjects and MethodsA study of 203 adults subjects consisting of 86 T2D subjects, and 77 T1D subjects stratified into remitters (n=49), and non-remitters (n=28). PR was defined as insulin-dose adjusted HbA1c of ≤9, and obesity as a BMI ≥30 kg/m2. Factor analysis was used to stratify the groups by ASCVD risk by factorizing seven lipid parameters (TC, LDL, HDL, non-HDL, TC/HDL, TG, TG/HDL) into 2 orthogonal factors (factor 1: TC*LDL; factor 2: HDL*TG) that explained 90% of the variance in the original seven parameters.ResultsThe analysis of individual lipid parameters showed that TC/HDL was similar between the controls and remitters (p=NS) but was significantly higher in the non-remitters compared to the remitters (p=0.026). TG/HDL was equally similar between the controls and remitters (p=NS) but was lower in the remitters compared to the non-remitters (p=0.007). TG was significantly lower in the remitters compared to T2D subjects (p<0.0001) but was similar between T2D subjects and non-remitters (p=NS). Non-HDL was significantly lower in the controls versus non-remitters (p=0.0003) but was similar between the controls and remitters (p=NS). Factor analysis showed that the means of factor 1 and factor 2 composite scores for dyslipidemia increased linearly from the controls, remitters, non-remitters to T2D, p value 0.0042 for factor 1, and <0.0001 for factor 2, with remitters having similar lipid phenotype as controls, while non-remitters were similar to T2D.ConclusionsPartial clinical remission of T1D is associated with a favorable early lipid phenotype which could translate to reduced long-term CVD risk in adults.Benjamin Udoka NwosuSadichchha ParajuliKrish KhatriGabrielle JasminLayana Al-HalbouniAustin F. LeeFrontiers Media S.A.articletype 1 diabetestype 2 diabetesadultshoneymoon phasepartial clinical remissioncardiovascular disease riskDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENFrontiers in Endocrinology, Vol 12 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
type 1 diabetes type 2 diabetes adults honeymoon phase partial clinical remission cardiovascular disease risk Diseases of the endocrine glands. Clinical endocrinology RC648-665 |
| spellingShingle |
type 1 diabetes type 2 diabetes adults honeymoon phase partial clinical remission cardiovascular disease risk Diseases of the endocrine glands. Clinical endocrinology RC648-665 Benjamin Udoka Nwosu Sadichchha Parajuli Krish Khatri Gabrielle Jasmin Layana Al-Halbouni Austin F. Lee Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes |
| description |
ImportanceRisk factors for atherosclerotic cardiovascular disease (ASCVD) are well established in type 2 diabetes (T2D), but not in type 1 diabetes (T1D). The impact of partial clinical remission (PR) on short-term ASCVD risk in T1D is unclear.AimTo investigate the impact of PR on the earliest ASCVD risk phenotype in adult T1D using factor analysis to compare the lipid phenotypes of T1D, T2D and controls after stratifying the T1D cohort into remitters and non-remitters.Subjects and MethodsA study of 203 adults subjects consisting of 86 T2D subjects, and 77 T1D subjects stratified into remitters (n=49), and non-remitters (n=28). PR was defined as insulin-dose adjusted HbA1c of ≤9, and obesity as a BMI ≥30 kg/m2. Factor analysis was used to stratify the groups by ASCVD risk by factorizing seven lipid parameters (TC, LDL, HDL, non-HDL, TC/HDL, TG, TG/HDL) into 2 orthogonal factors (factor 1: TC*LDL; factor 2: HDL*TG) that explained 90% of the variance in the original seven parameters.ResultsThe analysis of individual lipid parameters showed that TC/HDL was similar between the controls and remitters (p=NS) but was significantly higher in the non-remitters compared to the remitters (p=0.026). TG/HDL was equally similar between the controls and remitters (p=NS) but was lower in the remitters compared to the non-remitters (p=0.007). TG was significantly lower in the remitters compared to T2D subjects (p<0.0001) but was similar between T2D subjects and non-remitters (p=NS). Non-HDL was significantly lower in the controls versus non-remitters (p=0.0003) but was similar between the controls and remitters (p=NS). Factor analysis showed that the means of factor 1 and factor 2 composite scores for dyslipidemia increased linearly from the controls, remitters, non-remitters to T2D, p value 0.0042 for factor 1, and <0.0001 for factor 2, with remitters having similar lipid phenotype as controls, while non-remitters were similar to T2D.ConclusionsPartial clinical remission of T1D is associated with a favorable early lipid phenotype which could translate to reduced long-term CVD risk in adults. |
| format |
article |
| author |
Benjamin Udoka Nwosu Sadichchha Parajuli Krish Khatri Gabrielle Jasmin Layana Al-Halbouni Austin F. Lee |
| author_facet |
Benjamin Udoka Nwosu Sadichchha Parajuli Krish Khatri Gabrielle Jasmin Layana Al-Halbouni Austin F. Lee |
| author_sort |
Benjamin Udoka Nwosu |
| title |
Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes |
| title_short |
Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes |
| title_full |
Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes |
| title_fullStr |
Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes |
| title_full_unstemmed |
Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes |
| title_sort |
partial clinical remission reduces lipid-based cardiovascular risk in adult patients with type 1 diabetes |
| publisher |
Frontiers Media S.A. |
| publishDate |
2021 |
| url |
https://doaj.org/article/31ba85162293457e91654a534717c767 |
| work_keys_str_mv |
AT benjaminudokanwosu partialclinicalremissionreduceslipidbasedcardiovascularriskinadultpatientswithtype1diabetes AT sadichchhaparajuli partialclinicalremissionreduceslipidbasedcardiovascularriskinadultpatientswithtype1diabetes AT krishkhatri partialclinicalremissionreduceslipidbasedcardiovascularriskinadultpatientswithtype1diabetes AT gabriellejasmin partialclinicalremissionreduceslipidbasedcardiovascularriskinadultpatientswithtype1diabetes AT layanaalhalbouni partialclinicalremissionreduceslipidbasedcardiovascularriskinadultpatientswithtype1diabetes AT austinflee partialclinicalremissionreduceslipidbasedcardiovascularriskinadultpatientswithtype1diabetes |
| _version_ |
1718425851503050752 |